The majority of PTC+HT patients exhibit the Inf phenotype, characterized by an abundance of tumor-infiltrating immune cells, including CD8+ T cells and plasma cells, indicating activation of cellular and humoral immunity (49, 56). This evidence concerns the gene CD8A and neoplasm.